[Clinical trial of Trental 100 in patients with peripheral arterial occlusive diseases (author's transl)].MMW Munch Med Wochenschr. 1977 Jul 01; 119(26):901-4.MM
Abstract
The preparation Trental 100 was given to 73 patients in a vascular surgery department at a daily dose of 2-3 dragees over an average of 2-3 months. 51 of 67 patients with chronic arterial disorders of the lower extremities and 5 of 6 patients with circulatory disturbances in the brachial region improved, as measured by the walking distance, reactive hyperemia time, pain at rest and effect in tissue defects. Tests for objective tolerance showed no effects on the blood picture, liver and kidney functions and carbohydrate metabolism. In a few patients, subjective intolerance disappeared after reducing the dose.
MeSH
Pub Type(s)
Clinical Trial
English Abstract
Journal Article
Language
ger
PubMed ID
408616
Citation
von Westphalen, J G.. "[Clinical Trial of Trental 100 in Patients With Peripheral Arterial Occlusive Diseases (author's Transl)]." MMW, Munchener Medizinische Wochenschrift, vol. 119, no. 26, 1977, pp. 901-4.
von Westphalen JG. [Clinical trial of Trental 100 in patients with peripheral arterial occlusive diseases (author's transl)]. MMW Munch Med Wochenschr. 1977;119(26):901-4.
von Westphalen, J. G. (1977). [Clinical trial of Trental 100 in patients with peripheral arterial occlusive diseases (author's transl)]. MMW, Munchener Medizinische Wochenschrift, 119(26), 901-4.
von Westphalen JG. [Clinical Trial of Trental 100 in Patients With Peripheral Arterial Occlusive Diseases (author's Transl)]. MMW Munch Med Wochenschr. 1977 Jul 1;119(26):901-4. PubMed PMID: 408616.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - [Clinical trial of Trental 100 in patients with peripheral arterial occlusive diseases (author's transl)].
A1 - von Westphalen,J G,
PY - 1977/7/1/pubmed
PY - 1977/7/1/medline
PY - 1977/7/1/entrez
SP - 901
EP - 4
JF - MMW, Munchener medizinische Wochenschrift
JO - MMW Munch Med Wochenschr
VL - 119
IS - 26
N2 - The preparation Trental 100 was given to 73 patients in a vascular surgery department at a daily dose of 2-3 dragees over an average of 2-3 months. 51 of 67 patients with chronic arterial disorders of the lower extremities and 5 of 6 patients with circulatory disturbances in the brachial region improved, as measured by the walking distance, reactive hyperemia time, pain at rest and effect in tissue defects. Tests for objective tolerance showed no effects on the blood picture, liver and kidney functions and carbohydrate metabolism. In a few patients, subjective intolerance disappeared after reducing the dose.
SN - 0341-3098
UR - https://www.unboundmedicine.com/medline/citation/408616/[Clinical_trial_of_Trental_100_in_patients_with_peripheral_arterial_occlusive_diseases__author's_transl_]_
DB - PRIME
DP - Unbound Medicine
ER -